Viral infection: Moving through complex and dynamic cell-membrane structures

Communicative and Integrative Biology

Volumn 4, Issue 4, 2011, Pages 398-408

  Barroso González, Jonathan ^a,b   García Expósito, Laura ^a   Puigdomènech, Isabel ^c   de Armas Rillo, Laura ^a   Machado, José David ^a   Blanco, Julià ^c   Valenzuela Fernández, Agustín ^a  

^a Laboratorio de Neurosecreción   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Exosomes and trogocytosis; Membrane dynamics; Membrane associated viral factories; Viral budding; Viral fusion and entry; Viral synapse and spreading

Indexed keywords

EID: 79960105495     PISSN: None     EISSN: 19420889     Source Type: Journal    
DOI: 10.4161/cib.16716     Document Type: Review

References (199)

1. Greber UF, Way M. A superhighway to virus infection. Cell 2006; 124:741-54.
2. Marsh M, Helenius A. Virus entry: open sesame. Cell 2006; 124:729-40.
3. Gruenberg J. Viruses and endosome membrane dynamics. Curr Opin Cell Biol 2009; 21:582-8.
4. Bajno L, Peng XR, Schreiber AD, Moore HP, Trimble WS, Grinstein S. Focal exocytosis of VAMP3-containing vesicles at sites of phagosome formation. J Cell Biol 2000; 149:697-706.
5. Nordenfelt P, Winberg ME, Lonnbro P, Rasmusson B, Tapper H. Different requirements for early and late phases of azurophilic granule-phagosome fusion. Traffic 2009; 10:1881-93.
6. Faurschou M, Borregaard N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5:1317-27.
7. Maganto-Garcia E, Punzon C, Terhorst C, Fresno M. Rab5 activation by Toll-like receptor 2 is required for Trypanosoma cruzi internalization and replication in macrophages. Traffic 2008; 9:1299-315.
8. Miller S, Krijnse-Locker J. Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol 2008; 6:363-74.
9. Pierini R, Cottam E, Roberts R, Wileman T. Modulation of membrane traffic between endoplasmic reticulum, ERGIC and Golgi to generate compartments for the replication of bacteria and viruses. Semin Cell Dev Biol 2009; 20:828-33.
10. Hurley JH, Boura E, Carlson LA, Rozycki B. Membrane budding. Cell 2010; 143:875-87.
11. Mudhakir D, Harashima H. Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus. Aaps J 2009; 11:65-77.
12. Sodeik B. Mechanisms of viral transport in the cytoplasm. Trends Microbiol 2000; 8:465-72.
13. Doms RW, Trono D. The plasma membrane as a combat zone in the HIV battlefield. Genes Dev 2000; 14:2677-88.
14. Waheed AA, Freed EO. Lipids and membrane microdomains in HIV-1 replication. Virus Res 2009; 143:162-76.
15. Stein BS, Gowda SD, Lifson JD, Penhallow RC, Bensch KG, Engleman EG. pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 1987; 49:659-68.
16. + T cells. Adv Exp Med Biol 1991; 300:71-86.
17. Pelchen-Matthews A, Clapham P, Marsh M. Role of CD4 endocytosis in human immunodeficiency virus infection. J Virol 1995; 69:8164-8.
18. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens and immunogens. Science 1998; 280:1884-8.
19. Earp LJ, Delos SE, Park HE, White JM. The many mechanisms of viral membrane fusion proteins. Curr Top Microbiol Immunol 2005; 285:25-66.
20. Harrison SC. Mechanism of membrane fusion by viral envelope proteins. Adv Virus Res 2005; 64:231-61.
21. Behnia R, Munro S. Organelle identity and the signposts for membrane traffic. Nature 2005; 438:597-604.
22. Valenzuela-Fernandez A, Cabrero JR, Serrador JM, Sanchez-Madrid F. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol 2008; 18:291-7.
23. Albiges-Rizo C, Destaing O, Fourcade B, Planus E, Block MR. Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions. J Cell Sci 2009; 122:3037-49.
24. Mogilner A, Keren K. The shape of motile cells. Curr Biol 2009; 19:762-71.
25. Pollard TD, Cooper JA. Actin, a central player in cell shape and movement. Science 2009; 326:1208-12.
26. Saarikangas J, Zhao H, Lappalainen P. Regulation of the actin cytoskeleton-plasma membrane interplay by phosphoinositides. Physiol Rev 2010; 90:259-89.
27. Mellman I. Quo vadis: polarized membrane recycling in motility and phagocytosis. J Cell Biol 2000; 149:529-30.
28. Mellman I, Warren G. The road taken: past and future foundations of membrane traffic. Cell 2000; 100:99-112.
29. Heck JN, Mellman DL, Ling K, Sun Y, Wagoner MP, Schill NJ, et al. A conspicuous connection: structure defines function for the phosphatidylinositol-phosphate kinase family. Crit Rev Biochem Mol Biol 2007; 42:15-39.
30. Folsch H, Mattila PE, Weisz OA. Taking the scenic route: biosynthetic traffic to the plasma membrane in polarized epithelial cells. Traffic 2009; 10:972-81.
31. Shibata Y, Hu J, Kozlov MM, Rapoport TA. Mechanisms shaping the membranes of cellular organelles. Annu Rev Cell Dev Biol 2009; 25:329-54.
32. Iyengar S, Hildreth JE, Schwartz DH. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J Virol 1998; 72:5251-5.
33. Doms RW. Beyond receptor expression: the influence of receptor conformation, density and affinity in HIV-1 infection. Virology 2000; 276:229-37.
34. Kuhmann SE, Platt EJ, Kozak SL, Kabat D. Cooperation of multiple CCR5 coreceptors is required for infections by human immunodeficiency virus type. J Virol 2000; 74:7005-15.
35. Jimenez-Baranda S, Gomez-Mouton C, Rojas A, et al. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat Cell Biol 2007; 9:838-46.
36. Yoder A, Yu D, Dong L, Iyer SR, Xu X, Kelly J, et al. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008; 134:782-92.
37. Barrero-Villar M, Cabrero JR, Gordón-Alonso M, Barroso-González J, Alvarez-Losada S, Muñoz-Fernández MA, et al. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. J Cell Sci 2009; 122:103-13.
38. Sattentau Q. Avoiding the void: cell-to-cell spread of human viruses. Nat Rev Microbiol 2008; 6:815-26.
39. Barrero-Villar M, Barroso-González J, Cabrero JR, Gordón-Alonso M, Alvarez-Losada S, Muñoz-Fernández MA, et al. PI4P5-kinase Ialpha is required for efficient HIV-1 entry and infection of T cells. J Immunol 2008; 181:6882-8.
40. Liu Y, Belkina NV, Shaw S. HIV infection of T cells: actin-in and actin-out. Sci Signal 2009; 2:23.
41. Vorster PJ, Guo J, Yoder A, Wang W, Zheng Y, Xu X, et al. LIM Kinase 1 Modulates Cortical Actin and CXCR4 Cycling and Is Activated by HIV-1 to Initiate Viral Infection. J Biol Chem 2011; 286:12554-64.
42. Valenzuela-Fernández A, Alvarez S, Gordon-Alonso M, Barrero M, Ursa A, Cabrero JR, et al. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. Mol Biol Cell 2005; 16:5445-54.
43. Malinowsky K, Luksza J, Dittmar MT. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains. Virology 2008; 376:69-78.
44. Pauza CD, Price TM. Human immunodeficiency virus infection of T cells and monocytes proceeds via receptor-mediated endocytosis. J Cell Biol 1988; 107:959-68.
45. Marechal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J Virol 2001; 75:11166-77.
46. Daecke J, Fackler OT, Dittmar MT, Krausslich HG. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J Virol 2005; 79:1581-94.
47. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009; 137:433-44.
48. Carter GC, Bernstone L, Baskaran D, James W. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 2011; 409:234-50.
49. Yu D, Wang W, Yoder A, Spear M, Wu Y. The HIV envelope but not VSV glycoprotein is capable of mediating HIV latent infection of resting CD4 T cells. PLoS Pathog 2009; 5:1000633.
50. Harmon B, Campbell N, Ratner L. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog 2010; 6:1000956.
51. Garcia-Exposito L, Barroso-Gonzalez J, Puigdomenech I, Machado JD, Blanco J, Valenzuela-Fernandez A. HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes. Mol Biol Cell 2011; 22:1148-66.
52. Vidricaire G, Imbeault M, Tremblay MJ. Endocytic host cell machinery plays a dominant role in intracellular trafficking of incoming human immunodeficiency virus type 1 in human placental trophoblasts. J Virol 2004; 78:11904-15.
53. Vidricaire G, Tremblay MJ. Rab5 and Rab7, but not ARF6, govern the early events of HIV-1 infection in polarized human placental cells. J Immunol 2005; 175:6517-30.
54. Vidricaire G, Tremblay MJ. A clathrin, caveolae and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells. J Mol Biol 2007; 368:1267-83.
55. Honda A, Nogami M, Yokozeki T, Yamazaki M, Nakamura H, Watanabe H, et al. Phosphatidylinositol-4-phosphate-5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation. Cell 1999; 99:521-32.
56. Aikawa Y, Martin TF. ADP-ribosylation factor 6 regulation of phosphatidylinositol-4,5-bisphosphate synthesis, endocytosis and exocytosis. Methods Enzymol 2005; 404:422-31.
57. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG. Phosphatidylinositol-4,5-bisphosphate and Arf6-regulated membrane traffic. J Cell Biol 2001; 154:1007-17.
58. Donaldson JG. Multiple roles for Arf6: sorting, structuring and signaling at the plasma membrane. J Biol Chem 2003; 278:41573-6.
59. Wolf MC, Freiberg AN, Zhang T, et al. A broadspectrum antiviral targeting entry of enveloped viruses. Proc Natl Acad Sci USA 2010; 107:3157-62.
60. Criss AK, Silva M, Casanova JE, McCormick BA. Regulation of Salmonella-induced neutrophil transmigration by epithelial ADP-ribosylation factor 6. J Biol Chem 2001; 276:48431-9.
61. Smith AC, Cirulis JT, Casanova JE, Scidmore MA, Brumell JH. Interaction of the Salmonella-containing vacuole with the endocytic recycling system. J Biol Chem 2005; 280:24634-41.
62. Lodge R, Descoteaux A. Phagocytosis of Leishmania donovani amastigotes is Rac1 dependent and occurs in the absence of NADPH oxidase activation. Eur J Immunol 2006; 36:2735-44.
63. Nishi K, Saigo K. Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6. J Biol Chem 2007; 282:27503-17.
64. Muschiol S, Normark S, Henriques-Normark B, Subtil A. Small molecule inhibitors of the Yersinia type III secretion system impair the development of Chlamydia after entry into host cells. BMC Microbiol 2009; 9:75.
65. Marchant D, Sall A, Si X, Abraham T, Wu W, Luo Z, et al. ERK MAP kinase-activated Arf6 trafficking directs coxsackievirus type B3 into an unproductive compartment during virus host-cell entry. J Gen Virol 2009; 90:854-62.
66. Laakkonen JP, Mäkelä AR, Kakkonen E, Turkki P, Kukkonen S, Peränen J, et al. Clathrin-independent entry of baculovirus triggers uptake of E. coli in nonphagocytic human cells. PLoS One 2009; 4:5093.
67. Radhakrishna H, Donaldson JG. ADP-ribosylation factor 6 regulates a novel plasma membrane recycling pathway. J Cell Biol 1997; 139:49-61.
68. Donaldson JG, Honda A. Localization and function of Arf family GTPases. Biochem Soc Trans 2005; 33:639-42.
69. Naslavsky N, Weigert R, Donaldson JG. Convergence of non-clathrin- and clathrin-derived endosomes involves Arf6 inactivation and changes in phosphoinositides. Mol Biol Cell 2003; 14:417-31.
70. D'Souza-Schorey C, Li G, Colombo MI, Stahl PD. A regulatory role for ARF6 in receptor-mediated endocytosis. Science 1995; 267:1175-8.
71. Chavrier P, Goud B. The role of ARF and Rab GTPases in membrane transport. Curr Opin Cell Biol 1999; 11:466-75.
72. Al-Awar O, Radhakrishna H, Powell NN, Donaldson JG. Separation of membrane trafficking and actin remodeling functions of ARF6 with an effector domain mutant. Mol Cell Biol 2000; 20:5998-6007.
73. D'Souza-Schorey C, Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 2006; 7:347-58.
74. Song J, Khachikian Z, Radhakrishna H, Donaldson JG. Localization of endogenous ARF6 to sites of cortical actin rearrangement and involvement of ARF6 in cell spreading. J Cell Sci 1998; 111:2257.
75. Martin TF. PI(4,5)P(2) regulation of surface membrane traffic. Curr Opin Cell Biol 2001; 13:493-9.
76. Luton F, Klein S, Chauvin JP, Le Bivic A, Bourgoin S, Franco M, et al. EFA6, exchange factor for ARF6, regulates the actin cytoskeleton and associated tight junction in response to E-cadherin engagement. Mol Biol Cell 2004; 15:1134-45.
77. Donaldson JG. Arf6 and its role in cytoskeletal modulation. Methods Mol Biol 2002; 189:191-8.
78. Hernandez-Deviez DJ, Roth MG, Casanova JE, Wilson JM. ARNO and ARF6 regulate axonal elongation and branching through downstream activation of phosphatidylinositol-4-phosphate-5-kinase alpha. Mol Biol Cell 2004; 15:111-20.
79. Franco M, Peters PJ, Boretto J, van Donselaar E, Neri A, D'Souza-Schorey C, et al. EFA6, a sec7 domaincontaining exchange factor for ARF6, coordinates membrane recycling and actin cytoskeleton organization. EMBO J 1999; 18:1480-91.
80. Heikkilä O, Susi P, Tevaluoto T, Härmä H, Marjomäki V, Hyypiä T, et al. Internalization of coxsackievirus A9 is mediated by {beta}2-microglobulin, dynamin and Arf6 but not by caveolin-1 or clathrin. J Virol 2010; 84:3666-81.
81. Lichty BD, Power AT, Stojdl DF, Bell JC. Vesicular stomatitis virus: re-inventing the bullet. Trends Mol Med 2004; 10:210-6.
82. Schlegel R, Tralka TS, Willingham MC, Pastan I. Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 1983; 32:639-46.
83. Coil DA, Miller AD. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 2004; 78:10920-6.
84. Le Blanc I, Luyet PP, Pons V, Ferguson C, Emans N, Petiot A, et al. Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 2005; 7:653-64.
85. Luyet PP, Falguieres T, Pons V, Pattnaik AK, Gruenberg J. The ESCRT-I subunit TSG101 controls endosome-tocytosol release of viral RNA. Traffic 2008; 9:2279-90.
86. Rust MJ, Lakadamyali M, Zhang F, Zhuang X. Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol 2004; 11:567-73.
87. Chen C, Zhuang X. Epsin 1 is a cargo-specific adaptor for the clathrin-mediated endocytosis of the influenza virus. Proc Natl Acad Sci USA 2008; 105:11790-5.
88. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 2001; 3:473-83.
89. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A. Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 2005; 168:477-88.
90. Mayor S, Pagano RE. Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 2007; 8:603-12.
91. Neu U, Woellner K, Gauglitz G, Stehle T. Structural basis of GM1 ganglioside recognition by simian virus. Proc Natl Acad Sci USA 2008; 105:5219-24.
92. Pietiainen V, Marjomaki V, Upla P, Pelkmans L, Helenius A, Hyypia T. Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II and signaling events. Mol Biol Cell 2004; 15:4911-25.
93. Upla P, Marjomäki V, Kankaanpää P, Ivaska J, Hyypiä T, Van Der Goot FG, et al. Clustering induces a lateral redistribution of alpha2beta1 integrin from membrane rafts to caveolae and subsequent protein kinase C-dependent internalization. Mol Biol Cell 2004; 15:625-36.
94. Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 2005; 308:1643-5.
95. Ebert DH, Deussing J, Peters C, Dermody TS. Cathepsin L and cathepsin B mediate reovirus disassembly in murine fibroblast cells. J Biol Chem 2002; 277:24609-17.
96. Simmons G, Gosalia DN, Rennekamp AJ, Reeves JD, Diamond SL, Bates P. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci USA 2005; 102:11876-81.
97. Lehmann MJ, Sherer NM, Marks CB, Pypaert M, Mothes W. Actin- and myosin-driven movement of viruses along filopodia precedes their entry into cells. J Cell Biol 2005; 170:317-25.
98. Schelhaas M, Ewers H, Rajamaki ML, Day PM, Schiller JT, Helenius A. Human papillomavirus type 16 entry: retrograde cell surface transport along actin-rich protrusions. PLoS Pathog 2008; 4:1000148.
99. Mercer J, Helenius A. Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells. Science 2008; 320:531-5.
100. Karjalainen M, Kakkonen E, Upla P, Paloranta H, Kankaanpää P, Liberali P, et al. A Raft-derived, Pak1-regulated entry participates in alpha2beta1 integrindependent sorting to caveosomes. Mol Biol Cell 2008; 19:2857-69.
101. Liberali P, Kakkonen E, Turacchio G, Valente C, Spaar A, Perinetti G, et al. The closure of Pak1-dependent macropinosomes requires the phosphorylation of CtBP1/BARS. EMBO J 2008; 27:970-81.
102. Amstutz B, Gastaldelli M, Kälin S, Imelli N, Boucke K, Wandeler E, et al. Subversion of CtBP1-controlled macropinocytosis by human adenovirus serotype 3. EMBO J 2008; 27:956-69.
103. Netherton C, Moffat K, Brooks E, Wileman T. A guide to viral inclusions, membrane rearrangements, factories and viroplasm produced during virus replication. Adv Virus Res 2007; 70:101-82.
104. Novoa RR, Calderita G, Arranz R, Fontana J, Granzow H, Risco C. Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell 2005; 97:147-72.
105. Fontana J, Lopez-Montero N, Elliott RM, Fernandez JJ, Risco C. The unique architecture of Bunyamwera virus factories around the Golgi complex. Cell Microbiol 2008; 10:2012-28.
106. Fontana J, Lopez-Iglesias C, Tzeng WP, Frey TK, Fernandez JJ, Risco C. Three-dimensional structure of Rubella virus factories. Virology 2010; 405:579-91.
107. Salonen A, Ahola T, Kaariainen L. Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol 2005; 285:139-73.
108. Dye BT, Miller DJ, Ahlquist P. In vivo self-interaction of nodavirus RNA replicase protein a revealed by fluorescence resonance energy transfer. J Virol 2005; 79:8909-19.
109. Fontana J, Tzeng WP, Calderita G, Fraile-Ramos A, Frey TK, Risco C. Novel replication complex architecture in rubella replicon-transfected cells. Cell Microbiol 2007; 9:875-90.
110. Lyle JM, Bullitt E, Bienz K, Kirkegaard K. Visualization and functional analysis of RNA-dependent RNA polymerase lattices. Science 2002; 296:2218-22.
111. Mackenzie J. Wrapping things up about virus RNA replication. Traffic 2005; 6:967-77.
112. Spagnolo JF, Rossignol E, Bullitt E, Kirkegaard K. Enzymatic and nonenzymatic functions of viral RNAdependent RNA polymerases within oligomeric arrays. RNA 2010; 16:382-93.
113. Wang QM, Hockman MA, Staschke K, Johnson RB, Case KA, Lu J, et al. Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNAdependent RNA polymerase. J Virol 2002; 76:3865-72.
114. Frey TK. Molecular biology of rubella virus. Adv Virus Res 1994; 44:69-160.
115. Kujala P, Ikaheimonen A, Ehsani N, Vihinen H, Auvinen P, Kaariainen L. Biogenesis of the Semliki Forest virus RNA replication complex. J Virol 2001; 75:3873-84.
116. Kujala P, Ahola T, Ehsani N, Auvinen P, Vihinen H, Kaariainen L. Intracellular distribution of rubella virus nonstructural protein P150. J Virol 1999; 73:7805-11.
117. Lee JY, Marshall JA, Bowden DS. Characterization of rubella virus replication complexes using antibodies to double-stranded RNA. Virology 1994; 200:307-12.
118. Froshauer S, Kartenbeck J, Helenius A. Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes. J Cell Biol 1988; 107:2075-86.
119. Magliano D, Marshall JA, Bowden DS, Vardaxis N, Meanger J, Lee JY. Rubella virus replication complexes are virus-modified lysosomes. Virology 1998; 240:57-63.
120. Risco C, Carrascosa JL, Frey TK. Structural maturation of rubella virus in the Golgi complex. Virology 2003; 312:261-9.
121. James Morre D, Mollenhauer HH. Microscopic morphology and the origins of the membrane maturation model of Golgi apparatus function. Int Rev Cytol 2007; 262:191-218.
122. Salanueva IJ, Novoa RR, Cabezas P, López-Iglesias C, Carrascosa JL, Elliott RM, et al. Polymorphism and structural maturation of bunyamwera virus in Golgi and post-Golgi compartments. J Virol 2003; 77:1368-81.
123. Novoa RR, Calderita G, Cabezas P, Elliott RM, Risco C. Key Golgi factors for structural and functional maturation of bunyamwera virus. J Virol 2005; 79:10852-63.
124. Grimley PM, Levin JG, Berezesky IK, Friedman RM. Specific membranous structures associated with the replication of group A arboviruses. J Virol 1972; 10:492-503.
125. Cairns J. The initiation of vaccinia infection. Virology 1960; 11:603-23.
126. Kit S, Dubbs DR, Hsu TC. Biochemistry of vaccinia-infected mouse fibroblasts (strain L-M). III. Radioautographic and biochemical studies of thymidine-H3 uptake into DNA of L-M cells and rabbit cells in primary culture. Virology 1963; 19:13-22.
127. Tolonen N, Doglio L, Schleich S, Krijnse Locker J. Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei. Mol Biol Cell 2001; 12:2031-46.
128. Hall RA, Scherret JH, Mackenzie JS. Kunjin virus: an Australian variant of West Nile? Ann NY Acad Sci 2001; 951:153-60.
129. Pedersen KW, van der Meer Y, Roos N, Snijder EJ. Open reading frame 1a-encoded subunits of the arterivirus replicase induce endoplasmic reticulum-derived double-membrane vesicles which carry the viral replication complex. J Virol 1999; 73:2016-26.
130. van der Meer Y, van Tol H, Locker JK, Snijder EJ. ORF1a-encoded replicase subunits are involved in the membrane association of the arterivirus replication complex. J Virol 1998; 72:6689-98.
131. Hobson SD, Rosenblum ES, Richards OC, Richmond K, Kirkegaard K, Schultz SC. Oligomeric structures of poliovirus polymerase are important for function. EMBO J 2001; 20:1153-63.
132. Cherry S, Kunte A, Wang H, Coyne C, Rawson RB, Perrimon N. COPI activity coupled with fatty acid biosynthesis is required for viral replication. PLoS Pathog 2006; 2:102.
133. Belov GA, Ehrenfeld E. Involvement of cellular membrane traffic proteins in poliovirus replication. Cell Cycle 2007; 6:36-8.
134. Hogle JM. Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol 2002; 56:677-702.
135. Bubeck D, Filman DJ, Hogle JM. Cryo-electron microscopy reconstruction of a poliovirus-receptormembrane complex. Nat Struct Mol Biol 2005; 12:615-8.
136. Belov GA, Feng Q, Nikovics K, Jackson CL, Ehrenfeld E. A critical role of a cellular membrane traffic protein in poliovirus RNA replication. PLoS Pathog 2008; 4:1000216.
137. Maynell LA, Kirkegaard K, Klymkowsky MW. Inhibition of poliovirus RNA synthesis by brefeldin A. J Virol 1992; 66:1985-94.
138. Doedens JR, Kirkegaard K. Inhibition of cellular protein secretion by poliovirus proteins 2B and 3A. EMBO J 1995; 14:894-907.
139. Wessels E, Duijsings D, Lanke KH, van Dooren SH, Jackson CL, Melchers WJ, et al. Effects of picornavirus 3A Proteins on Protein Transport and GBF1-dependent COP-I recruitment. J Virol 2006; 80:11852-60.
140. Choe SS, Dodd DA, Kirkegaard K. Inhibition of cellular protein secretion by picornaviral 3A proteins. Virology 2005; 337:18-29.
141. Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P, Ryan MD, et al. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol 2005; 79:4382-95.
142. Gazina EV, Mackenzie JM, Gorrell RJ, Anderson DA. Differential requirements for COPI coats in formation of replication complexes among three genera of Picornaviridae. J Virol 2002; 76:11113-22.
143. Rust RC, Landmann L, Gosert R, Tang BL, Hong W, Hauri HP, et al. Cellular COPII proteins are involved in production of the vesicles that form the poliovirus replication complex. J Virol 2001; 75:9808-18.
144. Egger D, Bienz K. Intracellular location and translocation of silent and active poliovirus replication complexes. J Gen Virol 2005; 86:707-18.
145. Wei T, Wang A. Biogenesis of cytoplasmic membranous vesicles for plant potyvirus replication occurs at endoplasmic reticulum exit sites in a COPI- and COPIIdependent manner. J Virol 2008; 82:12252-64.
146. Jackson WT, Giddings TH Jr, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, et al. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol 2005; 3:156.
147. Ehrlich M, Boll W, Van Oijen A, Hariharan R, Chandran K, Nibert ML, et al. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell 2004; 118:591-605.
148. Vonderheit A, Helenius A. Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLoS Biol 2005; 3:233.
149. Tu H, Gao L, Shi ST, Taylor DR, Yang T, Mircheff AK, et al. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. Virology 1999; 263:30-41.
150. Hamamoto I, Nishimura Y, Okamoto T, Aizaki H, Liu M, Mori Y, et al. Human VAP-B is involved in hepatitis C virus replication through interaction with NS5A and NS5B. J Virol 2005; 79:13473-82.
151. Sklan EH, Serrano RL, Einav S, Pfeffer SR, Lambright DG, Glenn JS. TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. J Biol Chem 2007; 282:36354-61.
152. Stone M, Jia S, Heo WD, Meyer T, Konan KV. Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery. J Virol 2007; 81:4551-63.
153. Manna D, Aligo J, Xu C, Park WS, Koc H, Heo WD, et al. Endocytic Rab proteins are required for hepatitis C virus replication complex formation. Virology 398:21-37.
154. Ettayebi K, Hardy ME. Norwalk virus nonstructural protein p48 forms a complex with the SNARE regulator VAP-A and prevents cell surface expression of vesicular stomatitis virus G protein. J Virol 2003; 77:11790-7.
155. Chen BJ, Lamb RA. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 2008; 372:221-32.
156. Welsch S, Muller B, Krausslich HG. More than one door-Budding of enveloped viruses through cellular membranes. FEBS Lett 2007; 581:2089-97.
157. Bieniasz PD. Late budding domains and host proteins in enveloped virus release. Virology 2006; 344:55-63.
158. Morita E, Sundquist WI. Retrovirus budding. Annu Rev Cell Dev Biol 2004; 20:395-425.
159. Freed EO. Viral late domains. J Virol 2002; 76:4679-87.
160. Gruenberg J, Stenmark H. The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004; 5:317-23.
161. Piper RC, Katzmann DJ. Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 2007; 23:519-47.
162. Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 2010; 11:556-66.
163. Saksena S, Emr SD. ESCRTs and human disease. Biochem Soc Trans 2009; 37:167-72.
164. Rodahl LM, Stuffers S, Lobert VH, Stenmark H. The role of ESCRT proteins in attenuation of cell signaling. Biochem Soc Trans 2009; 37:137-42.
165. Fujii K, Munshi UM, Ablan SD, Demirov DG, Soheilian F, Nagashima K, et al. Functional role of Alix in HIV-1 replication. Virology 2009; 391:284-92.
166. Zhang Y, Qian H, Love Z, Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J Virol 1998; 72:1782-9.
167. Popova E, Popov S, Gottlinger HG. Human immunodeficiency virus type 1 nucleocapsid p1 confers ESCRT pathway dependence. J Virol 2010; 84:6590-7.
168. Bruce EA, Medcalf L, Crump CM, Noton SL, Stuart AD, Wise HM, et al. Budding of filamentous and non-filamentous influenza A virus occurs via a VPS4 and VPS28-independent pathway. Virology 2009; 390:268-78.
169. Chen BJ, Leser GP, Morita E, Lamb RA. Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol 2007; 81:7111-23.
170. Chukkapalli V, Hogue IB, Boyko V, Hu WS, Ono A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J Virol 2008; 82:2405-17.
171. Ono A, Ablan SD, Lockett SJ, Nagashima K, Freed EO. Phosphatidylinositol-(4,5)-bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc Natl Acad Sci USA 2004; 101:14889-94.
172. Kisseleva MV, Wilson MP, Majerus PW. The isolation and characterization of a cDNA encoding phospholipid-specific inositol polyphosphate-5-phosphatase. J Biol Chem 2000; 275:20110-6.
173. Shnyrova AV, Ayllon J, Mikhalyov II, Villar E, Zimmerberg J, Frolov VA. Vesicle formation by selfassembly of membrane-bound matrix proteins into a fluidlike budding domain. J Cell Biol 2007; 179:627-33.
174. Solon J, Gareil O, Bassereau P, Gaudin Y. Membrane deformations induced by the matrix protein of vesicular stomatitis virus in a minimal system. J Gen Virol 2005; 86:3357-63.
175. Irie T, Licata JM, Jayakar HR, Whitt MA, Bell P, Harty RN. Functional analysis of late-budding domain activity associated with the PSAP motif within the vesicular stomatitis virus M protein. J Virol 2004; 78:7823-7.
176. Piguet V, Sattentau Q. Dangerous liaisons at the virological synapse. J Clin Invest 2004; 114:605-10.
177. Jolly C, Sattentau QJ. Retroviral spread by induction of virological synapses. Traffic 2004; 5:643-50.
178. Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, et al. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003; 299:1713-6.
179. Jolly C, Kashefi K, Hollinshead M, Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actindependent synapse. J Exp Med 2004; 199:283-93.
180. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 1993; 67:2182-90.
181. Martin N, Sattentau Q. Cell-to-cell HIV-1 spread and its implications for immune evasion. Curr Opin HIV AIDS 2009; 4:143-9.
182. Massanella M, Puigdomènech I, Cabrera C, Fernandez-Figueras MT, Aucher A, Gaibelet G, et al. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells. Aids 2009; 23:183-8.
183. Martin N, Welsch S, Jolly C, Briggs JA, Vaux D, Sattentau QJ. Virological synapse-mediated spread of human immunodeficiency virus type 1 between T cells is sensitive to entry inhibition. J Virol 2010; 84:3516-27.
184. Jolly C, Sattentau QJ. Human immunodeficiency virus type 1 virological synapse formation in T cells requires lipid raft integrity. J Virol 2005; 79:12088-94.
185. Jolly C, Mitar I, Sattentau QJ. Requirement for an intact T-cell actin and tubulin cytoskeleton for efficient assembly and spread of human immunodeficiency virus type 1. J Virol 2007; 81:5547-60.
186. Puigdomenech I, Massanella M, Cabrera C, Clotet B, Blanco J. On the steps of cell-to-cell HIV transmission between CD4 T cells. Retrovirology 2009; 6:89.
187. Pais-Correia AM, Sachse M, Guadagnini S, Robbiati V, Lasserre R, Gessain A, et al. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat Med 2010; 16:83-9.
188. Sherer NM, Lehmann MJ, Jimenez-Soto LF, Horensavitz C, Pypaert M, Mothes W. Retroviruses can establish filopodial bridges for efficient cell-to-cell transmission. Nat Cell Biol 2007; 9:310-5.
189. Sowinski S, Jolly C, Berninghausen O, Purbhoo MA, Chauveau A, Köhler K, et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat Cell Biol 2008; 10:211-9.
190. Joly E, Hudrisier D. What is trogocytosis and what is its purpose? Nat Immunol 2003; 4:815.
191. +T cells play a role in HIV spreading? J Biomed Biotechnol 2010; 2010:907371.
192. Halary F, Amara A, Lortat-Jacob H, Messerle M, Delaunay T, Houlès C, et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002; 17:653-64.
193. Izquierdo-Useros N, Naranjo-Gómez M, Erkizia I, Puertas MC, Borràs FE, Blanco J, et al. HIV and mature dendritic cells: Trojan exosomes riding the Trojan horse? PLoS Pathog 2010; 6:1000740.
194. Izquierdo-Useros N, Puertas MC, Borras FE, Blanco J, Martinez-Picado J. Exosomes and retroviruses: the chicken or the egg? Cell Microbiol 2011; 13:10-7.
195. van Kooyk Y, Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003; 3:697-709.
196. Brandenburg B, Zhuang X. Virus trafficking-learning from single-virus tracking. Nat Rev Microbiol 2007; 5:197-208.
197. McIntosh R, Nicastro D, Mastronarde D. New views of cells in 3D: an introduction to electron tomography. Trends Cell Biol 2005; 15:43-51.
198. Kopek BG, Perkins G, Miller DJ, Ellisman MH, Ahlquist P. Three-dimensional analysis of a viral RNA replication complex reveals a virus-induced miniorganelle. PLoS Biol 2007; 5:220.
199. Diestra E, Fontana J, Guichard P, Marco S, Risco C. Visualization of proteins in intact cells with a clonable tag for electron microscopy. J Struct Biol 2009; 165:157-68.